AstraZeneca May Not Stay in Vaccines, but CEO Has No COVID Regrets
AstraZeneca may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the first COVID-19 shots but has since lost out to rivals.
Reuters Health Information
source https://www.medscape.com/viewarticle/979613?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/979613?src=rss
Comments
Post a Comment